Overview In June 2021 Belgium's Pharmaceutical products exports accounted up to €5.35B and imports accounted up to €3.07B, resulting in a positive trade balance of €2.28B. Between June 2020 and June 2021 the exports of Belgium's Pharmaceutical products have increased by €1.74B (48%) from €3.61B to €5.35B, while imports increased by €213M (7.45%) from €2.86B to €3.07B.
Destinations In June 2021, Pharmaceutical products were exported mostly to Germany (€1.54B), United States (€599M), Japan (€529M), United Kingdom (€341M), and France (€268M), and were imported mostly from Switzerland (€609M), Ireland (€504M), France (€473M), Italy (€411M), and United States (€308M).
Growth In June 2021, the increase in Pharmaceutical products's year-by-year exports was explained primarily by an increase in exports to Germany (€1.13B or 277%), Japan (€383M or 261%), and United Kingdom (€244M or 254%). In June 2021, the increase in Pharmaceutical products's year-by-year imports was explained primarily by an increase in imports from Switzerland (€227M or 59.3%), France (€179M or 61%), and Germany (€94.2M or 44.8%).